Edition:
United States

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

6.72CNY
25 Jul 2016
Change (% chg)

-- (--)
Prev Close
¥6.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,068,488
52-wk High
¥11.13
52-wk Low
¥5.31

600812.SS

Chart for 600812.SS

About

North China Pharmaceutical Company. Ltd is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company's main products are classified as penicillin, cephalosporin, vitamin and other products, including bulk pharmaceuticals, finish preparations and healthcare products, among... (more)
No analyst recommendations are available for 600812.SS.

Overall

Beta: 1.21
Market Cap(Mil.): ¥10,991.62
Shares Outstanding(Mil.): 1,630.81
Dividend: 0.02
Yield (%): 0.30

Financials

  600812.SS Industry Sector
P/E (TTM): 185.67 36.15 37.05
EPS (TTM): 0.04 -- --
ROI: 0.67 15.11 14.35
ROE: 1.13 16.17 15.56

BRIEF-North China Pharmaceutical unit gets GMP certificate

* Says it unit receives goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration

Jul 05 2016

BRIEF-North China Pharmaceutical unit gets WHO PQ authentication

* Says its unit gets WHO PQ(Confirmation of WHO Active Pharmaceutical Ingredient Pre-qualification) authentication for its streptomycin sulfate

Jun 28 2016

BRIEF-North China Pharmaceutical to pay 2015 dividend on June 21

* Says it will pay cash dividend of 0.02 yuan per share (before tax) for 2015 to shareholders of A shares of record on June 20

Jun 15 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.